Psoriasis and REMICADE (infliximab) Treatment
Links shared publicly online about this topic.
- 1,220total visits
Psoriasis and REMICADE (infliximab) Treatment
View full resource at remicade.com
Tags: Skin, Psoriasis, Crohn's Disease Medication, Ulcerative Colitis Medication, Rheumatoid Arthritis Medication, Remicade
Most Recently Shared on April 23, 2010 at 3:19 am By:
In a clinical study, 8 out of 10 psoriasis patients achieved at least 75% skin clearance within 10 weeks using Remicade.http://bit.ly/9f6XcE
EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC
news-medical.net — “MSD today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the use of REMICADE (infliximab) in the treatment of severely active ulcerative colitis (UC) in pediatric patients ages 6 to 17 years, who have had an inadequate response to conventional therapy, including corticosteroids and 6-mercaptopurine or azathioprine, or who are intolerant to or have medical contraindications for such therapies.” View full resource at news-medical.net
Most Recently Shared on January 21, 2012 at 9:30 am By:
Arthritis News: EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC: MSD today anno... http://t.co/qMuhwKHJ
REMICADE® Receives FDA Approval As First Biologic Treatment For Pediatric Ulcerative Colitis
medicalnewstoday.com — “Janssen Biotech, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved REMICADE® (infliximab) for the treatment of moderately to severely active ulcerative colitis” View full resource at medicalnewstoday.com
Most Recently Shared on September 24, 2011 at 8:05 am By:
Crohn Disease Wisdom OW Health
REMICADE® Receives FDA Approval As First Biologic Treatment For Pediatric Ulcerative Colitis: Janssen Biotech, ... http://t.co/maXFag05
New report on the immunomodulators market outlook to 2016
news-medical.net — “TNF inhibitors indicated for the treatment of rheumatoid arthritis, psoriasis and inflammatory bowel disease formed the largest share of the market, according to a new report available on companiesandmarkets.com. The top three products: Remicade, Humira and Enbrel accounted for 40.1% of the market in 2010.” View full resource at news-medical.net
Most Recently Shared on August 23, 2011 at 10:39 am By:
Arthritis News: New report on the immunomodulators market outlook to 2016: TNF inhibitors indicated for the trea... http://t.co/1Xp7voQ
FDA Panel Backs Remicade for Kids With Ulcerative Colitis - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- SILVER SPRING, Md. -- An FDA advisory panel has recommended expanding the indication for infliximab (Remicade) to include treatment of ulcerative colitis in children.” View full resource at qualitypointtech.net
Most Recently Shared on July 21, 2011 at 10:45 pm By:
FDA Panel Backs Remicade for Kids With Ulcerative Colitis: (MedPage Today) -- SILVER SPRING, Md. -- An FDA advisor... http://bit.ly/na9znL
Medical News: FDA Panel Backs Remicade for Kids With Ulcerative Colitis - in Gastroenterology, Inflammatory Bowel Disease from MedPage Today
medpagetoday.com — “SILVER SPRING, Md. -- An FDA advisory panel has recommended expanding the indication for infliximab (Remicade) to include treatment of ulcerative colitis in children.” View full resource at medpagetoday.com
Most Recently Shared on July 21, 2011 at 10:16 pm By:
FDA Panel Backs Remicade for Kids With Ulcerative Colitis http://bit.ly/q09fHV
Dramatic Response of Nail Psoriasis to Infliximab
hindawi.com — “Nail psoriasis, affecting up to 50% of psoriatic patients, is an important cause of serious psychological and physical distress. Traditional treatments for nail psoriasis, which include topical or intralesional corticosteroids, topical vitamin D analogues, photochemotherapy, oral retinoids, methotrexate, and cyclosporin, can be time-consuming, painful, or limited by significant toxicities. Biological agents may have the potential to revolutionize the management of patients with disabling nail ps” View full resource at hindawi.com
Most Recently Shared on May 12, 2011 at 7:04 am By:
Dramatic Response of Nail Psoriasis to Infliximab: We present another case of disabling nail psoriasis that resp... http://bit.ly/klsSrD
Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients - MPR
empr.com — “Centocor Ortho Biotech announced results from its Phase 3 study of Remicade (infliximab) in the treatment of pediatric patients with moderately to severely active ulcerative colitis (UC).” View full resource at empr.com
Most Recently Shared on May 10, 2011 at 3:54 pm By:
MPR News: Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients: Centocor Ortho Biotech announc... http://bit.ly/mK0h6c
Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients - ONA
oncologynurseadvisor.com — “Centocor Ortho Biotech announced results from its Phase 3 study of Remicade (infliximab) in the treatment of pediatric patients with moderately to severely active ulcerative colitis (UC).” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 10, 2011 at 3:36 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients http://goo.gl/fb/qYVQj
Supplemental BLA submitted for Remicade for pediatric ulcerative colitis - MPR
empr.com — “Centocor Ortho Biotech announced that it submitted a supplemental Biologics License Application (sBLA) to the FDA for Remicade (infliximab) for the treatment of moderately to severely active ulcerative colitis (UC) in pediatric patients who have had an inadequate response to conventional therapy.” View full resource at empr.com
Most Recently Shared on December 29, 2010 at 4:14 pm By:
MPR News: Supplemental BLA submitted for Remicade for pediatric ulcerative colitis: Centocor Ortho Biotech annou... http://bit.ly/erEMRU
Pediatrics Article | Psoriasis
mdlinx.com — “Occurrence of Pustular Psoriasis after Treatment of Crohn Disease with Infliximab” View full resource at mdlinx.com
Most Recently Shared on November 2, 2010 at 1:39 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Occurrence of Pustular Psoriasis after Treatment of Crohn Disease with Infliximab: Pediatric Dermatology http://bit.ly/bw5s1p #peds
Clinical Cases and Images: CasesBlog: Stelara (ustekinumab) and Remicade (infliximab) are effective if Enbrel (etanercept) stops working in psoriasis
casesblog.blogspot.com — “Health News Updated Daily by an Assistant Professor at University of Chicago, Internist and Allergist” View full resource at casesblog.blogspot.com
Most Recently Shared on October 29, 2010 at 2:33 am By:
Richard L.Trader,Sr Health Executive, Physician Assistant, and Therapist
Stelara (ustekinumab) and Remicade (infliximab) are effective if Enbrel (etanercept) stops working in psoriasis: A... http://bit.ly/cUPSQZ
Successful treatment of hand and foot psoriasis wi... [Dermatol Online J. 2010] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on August 4, 2010 at 12:25 pm By:
Successful treatment of hand and foot psoriasis with infliximab.: This report provides preliminary evidence to sup... http://bit.ly/9WQTzJ
Study shows Remicade can clear psoriasis even after patients fail on other biologic | Psoriasis Cure Now!
psoriasis-cure-now.org — “A study of Remicade (infliximab) in patients who had already failed to respond adequately to a similar biologic showed that Remicade was still often successful” View full resource at psoriasis-cure-now.org
Most Recently Shared on August 2, 2010 at 10:39 pm By:
Psoriasis Cure Now Health Organization
Study shows Remicade can clear psoriasis even after patients fail on other biologic http://is.gd/dZ3VI
REMICADE (infliximab) and AS ? ASSERT Study
remicade.com — “Approval of REMICADE in the treatment of ankylosing spondylitis was based on the results of the landmark ASSERT study.” View full resource at remicade.com
Most Recently Shared on April 25, 2010 at 4:10 am By:
ASSERT study shows Remicade improves signs and symptoms in patients with ankylosing spondylitis. Read about it. http://bit.ly/bX6IDl
Pediatric Crohn's Clinical Study
remicade.com — “Read the clinical study about REMICADE" (infliximab) for pediatric Crohn's disease.” View full resource at remicade.com
Most Recently Shared on April 25, 2010 at 4:08 am By:
It is important that pediatric Crohn's patients receive effective treatment as early as possible. How Remicade can help.http://bit.ly/am8SCM
Advertisement
